ADIPOQ and type 2 diabetes mellitus: High circulating adiponectin is strongly associated with reduced cardiovascular risk; however, in obesity and type 2 diabetes, hypoadiponectinemia resulting from low adipose tissue adiponectin secretion favors the development of insulin resistance and cardiovascular disease [58].